Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
67
TRMK Quote, Financials, Valuation and Earnings
Last price:
$38.27
Seasonality move
:
1.61%
Day range:
$36.82 - $39.04
52-week range:
$29.77 - $40.73
Dividend yield:
2.45%
P/E ratio:
9.97x
P/S ratio:
4.93x
P/B ratio:
1.15x
Volume:
286.6K
Avg. volume:
311.3K
1-year change:
12.05%
Market cap:
$2.3B
Revenue:
$455.5M
EPS (TTM):
$3.84
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $607.8M | $543.7M | $536.2M | $590.4M | $455.5M | |
| Revenue Growth (YoY) | 13.58% | -10.56% | -1.37% | 10.11% | -22.85% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $278.3M | $289.7M | $261.6M | $281.8M | $285.5M | |
| Other Inc / (Exp) | -- | -- | -- | $39K | -$174.7M | |
| Operating Expenses | $281.4M | $292M | $161.9M | $275.6M | $285.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $189.8M | $175.4M | $59.1M | $181M | $34.1M | |
| Earnings of Discontinued Ops. | -- | -- | $11M | $12.2M | $177.8M | |
| Income Tax Expense | $29.8M | $28M | -$1.8M | $27.7M | -$11.2M | |
| Net Income to Company | $160M | $147.4M | $71.9M | $165.5M | $223M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $160M | $147.4M | $71.9M | $165.5M | $223M | |
| Basic EPS (Cont. Ops) | $2.52 | $2.35 | $1.17 | $2.71 | $3.65 | |
| Diluted EPS (Cont. Ops) | $2.51 | $2.34 | $1.17 | $2.70 | $3.63 | |
| Weighted Average Basic Share | $63.5M | $62.8M | $61.2M | $61.1M | $61.2M | |
| Weighted Average Diluted Share | $63.6M | $63M | $61.4M | $61.2M | $61.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $231.6M | $199.6M | $106.2M | $507M | $410M | |
| Revenue (Reported) | $607.8M | $543.7M | $536.2M | $590.4M | $455.5M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $231.6M | $199.6M | $106.2M | $507M | $410M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $137.8M | $126M | $163M | $146.6M | $167.7M | |
| Revenue Growth (YoY) | -6.68% | -8.59% | 29.39% | -10.02% | 14.38% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $72.7M | $71.1M | $76.4M | $70M | $72.7M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $73.4M | $71.6M | $76.7M | $70M | $72.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $61.2M | $33.9M | $59.6M | $45M | $65.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $3.4M | -- | |
| Income Tax Expense | $9.3M | $4.7M | $9.3M | $6.8M | $11.7M | |
| Net Income to Company | $52M | $29.2M | $50.3M | $41.5M | $53.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $52M | $29.2M | $50.3M | $41.5M | $53.6M | |
| Basic EPS (Cont. Ops) | $0.82 | $0.47 | $0.82 | $0.68 | $0.88 | |
| Diluted EPS (Cont. Ops) | $0.82 | $0.47 | $0.82 | $0.68 | $0.88 | |
| Weighted Average Basic Share | $63.4M | $61.5M | $61M | $61.1M | $60.8M | |
| Weighted Average Diluted Share | $63.6M | $61.7M | $61.2M | $61.3M | $61M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $68.4M | $38.3M | $120.9M | $142M | $142.4M | |
| Revenue (Reported) | $137.8M | $126M | $163M | $146.6M | $167.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $68.4M | $38.3M | $120.9M | $142M | $142.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $598.3M | $531.8M | $573.2M | $588M | $476.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $280.3M | $288.1M | $267M | $284.7M | $288.1M | |
| Other Inc / (Exp) | -- | -- | -- | $39K | -$174.7M | |
| Operating Expenses | $283.2M | $290.2M | $167M | $278.3M | $288.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $226.2M | $148.1M | $84.8M | $170M | $54.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $12.9M | $174.4M | |
| Income Tax Expense | $36.4M | $23.5M | $2.8M | $26.1M | -$6.3M | |
| Net Income to Company | $189.8M | $124.6M | $93M | $156.7M | $235.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $189.8M | $124.6M | $93M | $156.7M | $235.1M | |
| Basic EPS (Cont. Ops) | $3.00 | $1.99 | $1.51 | $2.57 | $3.85 | |
| Diluted EPS (Cont. Ops) | $3.00 | $1.99 | $1.51 | $2.57 | $3.84 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $258.7M | $169.5M | $188.9M | $531.6M | $410.4M | |
| Revenue (Reported) | $598.3M | $531.8M | $573.2M | $588M | $476.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $258.7M | $169.5M | $188.9M | $531.6M | $410.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $137.8M | $126M | $163M | $146.6M | $167.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $72.7M | $71.1M | $76.4M | $70M | $72.7M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $73.4M | $71.6M | $76.7M | $70M | $72.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $61.2M | $33.9M | $59.6M | $45M | $65.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $3.4M | -- | |
| Income Tax Expense | $9.3M | $4.7M | $9.3M | $6.8M | $11.7M | |
| Net Income to Company | $52M | $29.2M | $50.3M | $41.5M | $53.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $52M | $29.2M | $50.3M | $41.5M | $53.6M | |
| Basic EPS (Cont. Ops) | $0.82 | $0.47 | $0.82 | $0.68 | $0.88 | |
| Diluted EPS (Cont. Ops) | $0.82 | $0.47 | $0.82 | $0.68 | $0.88 | |
| Weighted Average Basic Share | $63.4M | $61.5M | $61M | $61.1M | $60.8M | |
| Weighted Average Diluted Share | $63.6M | $61.7M | $61.2M | $61.3M | $61M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $68.4M | $38.3M | $120.9M | $142M | $142.4M | |
| Revenue (Reported) | $137.8M | $126M | $163M | $146.6M | $167.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $68.4M | $38.3M | $120.9M | $142M | $142.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2B | $2.3B | $734.8M | $975.3M | $567.3M | |
| Short Term Investments | $2B | $3.2B | $2B | $1.8B | $1.7B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.9B | $5.5B | $2.8B | $2.7B | $2.3B | |
| Property Plant And Equipment | $225M | $236.5M | $248.7M | $266.7M | $269.1M | |
| Long-Term Investments | $2.5B | $3.6B | $3.5B | $3.2B | $3B | |
| Goodwill | $385.3M | $384.2M | $384.2M | $334.6M | $334.6M | |
| Other Intangibles | $73.9M | $92.8M | $133.3M | $132.1M | $139.4M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $16.6B | $17.6B | $18B | $18.7B | $18.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $305.7M | $323M | $520.1M | $484.6M | $421.6M | |
| Long-Term Debt | $204.1M | $185M | $1.2B | $585.4M | $385.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.8B | $15.9B | $16.5B | $17.1B | $16.2B | |
| Common Stock | $13.2M | $12.8M | $12.7M | $12.7M | $12.7M | |
| Other Common Equity Adj | -$1.1M | -$32.6M | -$275.4M | -$219.7M | -$83.7M | |
| Common Equity | $1.7B | $1.7B | $1.5B | $1.7B | $2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.7B | $1.7B | $1.5B | $1.7B | $2B | |
| Total Liabilities and Equity | $16.6B | $17.6B | $18B | $18.7B | $18.2B | |
| Cash and Short Terms | $3.9B | $5.5B | $2.8B | $2.7B | $2.3B | |
| Total Debt | $204.1M | $185M | $1.2B | $585.4M | $385.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.8B | $1.9B | $1.3B | $606.3M | $587.4M | |
| Short Term Investments | $2.3B | $3B | $2B | $1.7B | $33M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.1B | $4.9B | $3.3B | $2.3B | $620.4M | |
| Property Plant And Equipment | $232.8M | $241.3M | $259.3M | $269.6M | $265.1M | |
| Long-Term Investments | $2.8B | $3.6B | $3.5B | $3.1B | $3.1B | |
| Goodwill | $384.2M | $384.2M | $384.2M | $384.2M | $334.6M | |
| Other Intangibles | $89.8M | $115.6M | $130.6M | $140.9M | $134.4M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $16.9B | $17.4B | $18.9B | $18.4B | $18.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $161M | $170.5M | $478M | $393.2M | $360.1M | |
| Long-Term Debt | $330.7M | $269.6M | $1.7B | $667.4M | $590.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $15.1B | $15.8B | $17.3B | $16.7B | $16.3B | |
| Common Stock | $13.2M | $12.8M | $12.7M | $12.7M | $12.7M | |
| Other Common Equity Adj | -$16.5M | -$148.7M | -$242.4M | -$227.2M | -$48.7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.8B | $1.6B | $1.6B | $1.7B | $2B | |
| Total Liabilities and Equity | $16.9B | $17.4B | $18.9B | $18.4B | $18.3B | |
| Cash and Short Terms | $4.1B | $4.9B | $3.3B | $2.3B | $620.4M | |
| Total Debt | $330.7M | $269.6M | $1.7B | $667.4M | $590.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $160M | $147.4M | $71.9M | $165.5M | $223M | |
| Depreciation & Amoritzation | $41.3M | $45.8M | $39.9M | $35.8M | $38.1M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $65.3M | $348.8M | $296.5M | $196.9M | $116.9M | |
| Capital Expenditures | $30.8M | $31.2M | $34M | $48.7M | $28.6M | |
| Cash Acquisitions | -$7.9M | -- | -- | -- | $321.3M | |
| Cash From Investing | -$1.2B | -$1B | -$2.3B | -$411.2M | $284.6M | |
| Dividends Paid (Ex Special Dividend) | -$58.8M | -$58.1M | -$56.7M | -$56.7M | -$56.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $123.4M | -- | $975M | -- | -- | |
| Long-Term Debt Repaid | -$1.7M | -$1.4M | -$1.4M | -$575.7M | -$200.5M | |
| Repurchase of Common Stock | -$28.6M | -$61.8M | -$26.3M | -$1.1M | -$9M | |
| Other Financing Activities | -- | -$1.4M | -$1.7M | -$1.1M | -- | |
| Cash From Financing | $2.7B | $970.6M | $451.8M | $455M | -$809.6M | |
| Beginning Cash (CF) | $358.9M | $2B | $2.3B | $734.6M | $975.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.6B | $314.3M | -$1.5B | $240.8M | -$408.1M | |
| Ending Cash (CF) | $2B | $2.3B | $734.6M | $975.3M | $567.3M | |
| Levered Free Cash Flow | $34.5M | $317.6M | $262.5M | $148.2M | $88.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $52M | $29.2M | $50.3M | $41.5M | $53.6M | |
| Depreciation & Amoritzation | $11.1M | $10.4M | $7.7M | $8.6M | $8.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $83.3M | $61.9M | $2.6M | -$58.5M | $82.4M | |
| Capital Expenditures | $9M | $7.8M | $19.8M | $7.1M | $4.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$567.8M | -$344.5M | -$249.3M | -$51.3M | -$143.6M | |
| Dividends Paid (Ex Special Dividend) | -$14.7M | -$14.2M | -$14.2M | -$14.2M | -$14.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$358K | -$370K | -$347K | -$104K | -$112K | |
| Repurchase of Common Stock | -$5.4M | -$10.1M | -- | -- | -$15M | |
| Other Financing Activities | -- | -- | -$1M | -$1.4M | -$2.4M | |
| Cash From Financing | $306.5M | -$66.6M | $809.1M | -$259.4M | $81.3M | |
| Beginning Cash (CF) | $2B | $2.3B | $734.8M | $975.3M | $567.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$178M | -$349.3M | $562.4M | -$369.3M | $20.1M | |
| Ending Cash (CF) | $1.8B | $1.9B | $1.3B | $606.1M | $587.4M | |
| Levered Free Cash Flow | $74.4M | $54M | -$17.3M | -$65.6M | $78.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $189.8M | $124.6M | $93M | $156.7M | $235.1M | |
| Depreciation & Amoritzation | $43.5M | $45.1M | $37.1M | $36.7M | $38.1M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $227.9M | $327.3M | $237.2M | $135.8M | $257.9M | |
| Capital Expenditures | $33.8M | $30M | $46M | $35.9M | $25.8M | |
| Cash Acquisitions | -$4.8M | -- | -- | -- | $321.3M | |
| Cash From Investing | -$1.5B | -$781.8M | -$2.2B | -$213.2M | $192.3M | |
| Dividends Paid (Ex Special Dividend) | -$58.7M | -$57.6M | -$56.7M | -$56.7M | -$57.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.6M | -$1.4M | -$1.4M | -$575.5M | -$200.5M | |
| Repurchase of Common Stock | -$5.5M | -$66.5M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$1.4M | -- | |
| Cash From Financing | $2.6B | $597.5M | $1.3B | -$613.5M | -$468.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.4B | $143M | -$620.4M | -$690.9M | -$18.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $194M | $297.3M | $191.2M | $99.8M | $232.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $52M | $29.2M | $50.3M | $41.5M | $53.6M | |
| Depreciation & Amoritzation | $11.1M | $10.4M | $7.7M | $8.6M | $8.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $83.3M | $61.9M | $2.6M | -$58.5M | $82.4M | |
| Capital Expenditures | $9M | $7.8M | $19.8M | $7.1M | $4.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$567.8M | -$344.5M | -$249.3M | -$51.3M | -$143.6M | |
| Dividends Paid (Ex Special Dividend) | -$14.7M | -$14.2M | -$14.2M | -$14.2M | -$14.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$358K | -$370K | -$347K | -$104K | -$112K | |
| Repurchase of Common Stock | -$5.4M | -$10.1M | -- | -- | -$15M | |
| Other Financing Activities | -- | -- | -$1M | -$1.4M | -$2.4M | |
| Cash From Financing | $306.5M | -$66.6M | $809.1M | -$259.4M | $81.3M | |
| Beginning Cash (CF) | $2B | $2.3B | $734.8M | $975.3M | $567.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$178M | -$349.3M | $562.4M | -$369.3M | $20.1M | |
| Ending Cash (CF) | $1.8B | $1.9B | $1.3B | $606.1M | $587.4M | |
| Levered Free Cash Flow | $74.4M | $54M | -$17.3M | -$65.6M | $78.1M | |
Get TRMK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TRMK
Sector
P/E ratio
9.97x
12.21x
PEG ratio
0.20x
0.40x
P/B ratio
1.15x
1.11x
Price / LTM sales
4.93x
2.66x
Growth Metrics
TRMK
Sector
Revenue growth
14.38%
5.12%
Earnings growth
29.41%
2.63%
Revenue (5-year growth)
-3.17%
5.17%
Earnings forecast
$0.87
$0.61
Profitability
TRMK
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
9.54%
5.21%
Return on assets
1.28%
0.97%
Return on equity
12.34%
9.24%
Earnings Date
Last Earnings Date
Apr
22
Next Earnings Date
Jul
22
Estimated Next Earnings Date
Jul
22
Balance Sheet
TRMK
Sector
Total cash
$620.4M
$451.2M
Short term investments
$1.7B
$220.9M
Total assets
$18.2B
$3.8B
Long term debt
$590.4M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
